Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Phase II Platform Study to Evaluate Treatment With Cemiplimab Monotherapy or Cemiplimab Plus Fianlimab or Other Novel Combinations in Patients With Colorectal Cancer With Minimal Residual Disease Following Definitive Surgery and Chemotherapy (EMPIRE)Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colonic disorder, colonic neoplasm, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasmRecruitingPhase 22026-09-03NCT07058012

2 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
NSABP Foundation Inc10
Regeneron Pharmaceuticals238

13 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Allegheny General HospitalPittsburghUnited States146
Ballad Health Cancer Center - KingsportKingsportUnited States1
Bon Secours St. Francis Medical CenterMidlothianUnited States7
First Health of the CarolinasPinehurstUnited States2
Huntsman Cancer Institute - University of UtahSalt Lake CityUnited States7
Magee-Womens Hospital of UPMCPittsburghUnited States7
Missouri BaptistSt LouisUnited States2
University of FloridaGainesvilleUnited States79
University of Iowa - Holden Comprehensive Cancer CenterIowa CityUnited States1
University of Kansas Cancer CenterKansas CityUnited States242
University of Maryland GreenbaumBaltimoreUnited States1
University of Virginia HealthCharlottesvilleUnited States2
Virginia Commonwealth University - MasseyRichmondUnited States1